New biomarkers and risk stratification in atrial fibrillation: simplicity and practicality matter

Keyphrases

• New Biomarkers 100%
• New Risks 100%
• Risk Stratification 100%
• Atrial Fibrillation 100%
• Biomarker Stratification 100%
• Inflammation 50%
• Pathogenic Mechanism 50%
• Pathophysiology 50%
• Disease Process 50%
• Underlying Disease 50%
• Drug Efficacy 50%
• Clinical High Risk 50%
• Age-related Illnesses 50%
• Visceral Adipose Tissue 50%
• Von Willebrand Factor 50%
• Clot 50%
• Biological Markers 50%
• Polypharmacy 50%
• Blood-based 50%
• Inflammation Oxidative Stress 50%
• D-dimer 50%
• Clinical Risk Score 50%
• Thromboxane 50%
• Drug Toxicity 50%
• Cardiac Imaging 50%
• Collagen Turnover 50%
• Cerebral MRI 50%
• Everyday Clinical Practice 50%

Medicine and Dentistry

• Biological Marker 100%
• Risk Stratification 100%
• Atrial Fibrillation 100%
• Oxidative Stress 16%
• Disease Process 16%
• Obesity 16%
• Pathophysiology 16%
• Von Willebrand Factor 16%
• Polypharmacy 16%
• D-Dimer 16%
• Drug Efficacy 16%
• Drug Toxicity 16%
• Thromboxane 16%
• Diseases 16%